Skip to content

Enterprise value at other companies

AdaptHealth logo
AdaptHealthAHCO
$3.57B+1.7%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$1.1B-36.5%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
$1.51B+25.4%
ResMed logo
ResMedRMD
$32.14B-2.0%
UFP Technologies logo
UFP TechnologiesUFPT
$1.63B-6.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s enterprise value?
Viemed Healthcare, Inc. (VMD) reported enterprise value of $358.21M in Q1 2026.
How has Viemed Healthcare, Inc.'s enterprise value changed year-over-year?
Viemed Healthcare, Inc.'s enterprise value increased by 26.0% year-over-year, from $284.32M to $358.21M.
What is the long-term trend for Viemed Healthcare, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s enterprise value has grown at a 0.3% compound annual growth rate (CAGR), from $280.3M to $284.92M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.